The company was founded in 1982. MB Software Corporation runs business through its subsidiary Wound Care Innovations. It operates as a distributor of wound care products to healthcare providers in the United States. Wound Care primarily produces CellerateRX gel and powder. CellerateRX is a collagen-based wound care product line distributed in the domestic medical, retail, government and first aid wound care markets.
In October 3, 2006 the company has announced intentions to change their name from "MB Software Corporation" to "Wound Management Technologies, Inc.". It has also announced a possible authorized shares increase...
